Selbyville, Delaware , June 14, 2022 (GLOBE NEWSWIRE) —
The sleep apnea implants market value is expected to reach USD 1.2 billion by 2030, according to a new research report by Global Market Insights Inc. Increasing disease burden of sleep apnea along with incremental healthcare expenditure concerning with the disease is anticipated to drive the market expansion.
Research and development activities by key market players have led to the development of novel, minimally invasive implants for the treatment of obstructive sleep apnea. Hypoglossal nerve stimulation (HNS) therapy provides an advanced approach and a paradigm shift in obstructive sleep apnea (OSA) treatment. As compared to conventional sleep apnea surgical procedures, HNS promotes the neuromuscular functionality of the pharynx, facilitates upper airway structure, and has the potential to offer multilevel upper airway improvement. The efficacy of HNS has established a platform for novel technology development and application to other subsets of the OSA.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5279
Sleep apnea implants market from phrenic nerve stimulators exceeded USD 24 million in 2021. This is owing to the increasing adoption of phrenic nerve stimulators for the management of central sleep apnea. Phrenic nerve stimulation therapy is used to treat central sleep apnea. Clinical studies have reported high efficacy rates among people…
